Back to Top
Go Back
Journal Photo for Molecular & Cellular Oncology
Peer reviewed only Open Access

Molecular & Cellular Oncology (M&CO)

Publisher : Taylor & Francis, Inc
Mechanistic Transcriptomics proteomics
Claim Your Journal Get PRC Visit Website
e-ISSN 2372-3556
Issue Frequency Continuously
Impact Factor 2.6
Est. Year 2025
Mobile 12156258900
DOI YES
Language English
APC YES
Impact Factor Assignee Google Scholar
Email support@tandfonline.com

Journal Descriptions

Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print. Molecular & Cellular Oncology is an international journal publishing fundamental, translational and clinical research on all aspects of oncogenesis, tumor progression and therapeutic strategies. Topics covered include: All solid and hematological cancers; Mechanistic insights into molecular pathways and cellular processes; Cell growth regulation, signal transduction, and apoptosis; Tumor microenvironment and immunosurveillance; Transcriptomics, proteomics, and metabolomics. Molecular & Cellular Oncology publishes original research, reviews, short articles, commentaries, and author views.

Molecular & Cellular Oncology (M&CO) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Mechanistic, Transcriptomics, proteomics, metabolomics, Tumor microenvironment, immunosurveillance, Cell growth regulation, signal transduction, apoptosis , Online , Continuously Journal

  • UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2372-3556, Established: 2025, Impact Factor: 2.6
  • Provides Crossref DOI

  • Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE

Indexing

Publications of M&CO

ZNF768: controlling cellular senescence and proliferation with ten fingers
Romain Villot December, 2021
We recently identified Zinc-finger protein 768 (ZNF768) as a novel transcription factor controlling cell fate decision downstream of Rat sarcoma virus (RAS). We showed that ZNF768 depletion ...
(-)-Oleocanthal rapidly and selectively induces cancer cell death via lysosomal membrane permeabilization
Onica LeGendre July, 2015
(-)-Oleocanthal (OC), a phenolic compound present in extra-virgin olive oil (EVOO), has been implicated in the health benefits associated with diets rich in EVOO. We investigated the effect ...
Genomic profile, smoking, and response to anti-PD-1 therapy in non-small cell lung carcinoma
Timothy A. Chan January, 2016
The recent successes of immune checkpoint therapies have established a new era for the treatment of patients with cancer, yet the predictors of response remain largely undetermined. We recen...
Metagenomic insights into the plasma virome of Brazilian patients with prostate cancer
Svetoslav Nanev March, 2023
Growing evidence suggests that metavirome changes could be associated increased risk for malignant cell transformation. Considering Viruses have been proposed as factors for prostate cancer ...
The developmental gene Chordin is amplified and expressed in human cancers
Eric Sosa May, 2023
Chordin (CHRD) is a secreted protein important in early development, yet a role for CHRD in human disease has not been identified. In this study we investigated CHRD in cancer and normal adu...
The identification of key genes and pathways in glioblastoma by bioinformatics analysis
Najaf Allahyari August, 2023
GBM is the most common and aggressive type of brain tumor. It is classified as a grade IV tumor by the WHO, the highest grade. Prognosis is generally poor, with most patients surviving only ...
Establishment, authenticity, and characterization of cervical cancer cell lines
Luz Eugenia June, 2022
Cell lines have been considered excellent research models in many areas of biomedicine and, specifically, in the study of carcinogenesis. However, they cease to be effective models if their ...
Clemastine and hyperthermia enhance sensitization of osteosarcoma cells for apoptosis
Deepak Kumar May, 2024
Clemastine is an antagonist of histamine H1 receptor may provide benefits in the treatment of osteosarcoma (OS). In the current study, we used hyperthermia approach to sensitize OS cells to ...
Amino acid deprivation in cancer cells with compensatory autophagy induction increases sensitivity to autophagy inhibitors
Takahito Fukui July, 2024
Inhibition of autophagy is an important strategy in cancer therapy. However, prolonged inhibition of certain autophagies in established cancer cells may increase therapeutic resistance, thou...
Selection forces underlying aneuploidy patterns in cancer
Christopher S. June, 2024
Aneuploidy, the presence of an aberrant number of chromosomes, has been associated with tumorigenesis for over a century. More recently, advances in karyotyping techniques have revealed its ...